Objectives. To identify predictors of smoking abstinence at the end of medication use that could assist in the optimal use of a sustained-release (SR) form of bupropion for treating cigarette smokers.

Bupropion is approved by the U.S. Food and Drug Administration (FDA) for depression, seasonal affective disorder and smoking cessation. This medication is also frequently used to treat ADHD ...

Dr Julian Spinks is a Kent GP and a member of Smoking Cessation Action in Primary Care, SCAPE. He says: "The patients I have prescribed with Zyban have had extremely positive results with it.

you may already know about the anti-smoking drug Zyban. The popular drug is thought to double your chances of quitting and is the next obvious step to take after nicotine replacement therapies ...

A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...

Switching to Wellbutrin XL: give same total daily dose. Not for treating bipolar depression or for smoking cessation. Increased risk of suicidal thinking and behavior in children, adolescents ...

Recent Cochrane reviews highlight effective smoking cessation interventions ... the additive effects of combining GLP-1 analog with bupropion/naltrexone on weight loss, finding potential benefits ...

Other forms of bupropion (eg, Zyban). Not for treating bipolar depression or for smoking cessation. Increased risk of suicidal thinking and behavior in children, adolescents, and young adults ...

The US Court of Appeals for the Federal Circuit in Washington DC has ruled in favour of one generic company but against another in an infringement case concerning GSK's US patent 5,427,798 for the ...

This study included 615 cigarette smokers who received placebo (n = 153), or 100 mg (n = 153), 150 mg (n = 153), or 300 mg (n = 156) bupropion SR treatment as an intervention for smoking.